These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18214171)

  • 1. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand.
    Akksilp S; Karnkawinpong O; Wattanaamornkiat W; Viriyakitja D; Monkongdee P; Sitti W; Rienthong D; Siraprapasiri T; Wells CD; Tappero JW; Varma JK
    Emerg Infect Dis; 2007 Jul; 13(7):1001-7. PubMed ID: 18214171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand.
    Sanguanwongse N; Cain KP; Suriya P; Nateniyom S; Yamada N; Wattanaamornkiat W; Sumnapan S; Sattayawuthipong W; Kaewsa-ard S; Ingkaseth S; Varma JK
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):181-9. PubMed ID: 18520676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.
    Caro-Vega Y; Schultze A; W Efsen AM; Post FA; Panteleev A; Skrahin A; Miro JM; Girardi E; Podlekareva DN; Lundgren JD; Sierra-Madero J; Toibaro J; Andrade-Villanueva J; Tetradov S; Fehr J; Caylà J; Losso MH; Miller RF; Mocroft A; Kirk O; Crabtree-Ramírez B
    BMC Infect Dis; 2018 Apr; 18(1):191. PubMed ID: 29685113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
    Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection.
    Buck WC; Olson D; Kabue MM; Ahmed S; Nchama LK; Munthali A; Hosseinipour MC; Kazembe PN
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1389-95. PubMed ID: 24125439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Flick RJ; Kim MH; Simon K; Munthali A; Hosseinipour MC; Rosenberg NE; Kazembe PN; Mpunga J; Ahmed S
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1046-54. PubMed ID: 27393538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
    Tshitenge S; Ogunbanjo GA; Citeya A
    Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
    Tweya H; Feldacker C; Phiri S; Ben-Smith A; Fenner L; Jahn A; Kalulu M; Weigel R; Kamba C; Banda R; Egger M; Keiser O
    PLoS One; 2013; 8(2):e56248. PubMed ID: 23457534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of antituberculosis treatments at 18 months follow-up in TB-HIV co-infected patients on ART: a retrospective review of 166 cases.
    Chunpongthong P; Ko ZZ; Yeekian C; Luvira V; Pitisuttithum P
    J Med Assoc Thai; 2011 Jun; 94(6):664-70. PubMed ID: 21696073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.
    Manosuthi W; Chottanapand S; Thongyen S; Chaovavanich A; Sungkanuparph S
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):42-6. PubMed ID: 16885778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.
    Patel MR; Yotebieng M; Behets F; Vanden Driessche K; Nana M; Van Rie A
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1206-11. PubMed ID: 23827656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.
    Webb Mazinyo E; Kim L; Masuku S; Lancaster JL; Odendaal R; Uys M; Podewils LJ; Van der Walt ML
    PLoS One; 2016; 11(7):e0159317. PubMed ID: 27442440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.